Stevanato Group S.p.A. (STVN)
USD 22.47
(-5.07%)
USD 22.47
(-5.07%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 265.64 Million EUR | 24.54% |
| 2022 | 213.3 Million EUR | 43.25% |
| 2021 | 148.9 Million EUR | 6.84% |
| 2020 | 139.37 Million EUR | 5.68% |
| 2019 | 131.88 Million EUR | 33.74% |
| 2018 | 98.61 Million EUR | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 302.95 Million EUR | 6.85% |
| 2024 Q1 | 283.35 Million EUR | 6.67% |
| 2023 Q3 | 277.1 Million EUR | 2.9% |
| 2023 Q2 | 269.3 Million EUR | 9.72% |
| 2023 FY | 265.64 Million EUR | 24.54% |
| 2023 Q1 | 245.45 Million EUR | 15.07% |
| 2023 Q4 | 265.64 Million EUR | -4.13% |
| 2022 Q3 | 218.05 Million EUR | 13.25% |
| 2022 Q2 | 192.53 Million EUR | 15.46% |
| 2022 FY | 213.3 Million EUR | 43.25% |
| 2022 Q1 | 166.76 Million EUR | 12.0% |
| 2022 Q4 | 213.3 Million EUR | -2.18% |
| 2021 Q1 | 151.34 Million EUR | 8.59% |
| 2021 FY | 148.9 Million EUR | 6.84% |
| 2021 Q3 | 148.32 Million EUR | -0.93% |
| 2021 Q2 | 149.71 Million EUR | -1.08% |
| 2021 Q4 | 148.9 Million EUR | 0.38% |
| 2020 Q4 | 139.37 Million EUR | 0.0% |
| 2020 FY | 139.37 Million EUR | 5.68% |
| 2020 Q1 | - EUR | 0.0% |
| 2019 FY | 131.88 Million EUR | 33.74% |
| 2018 FY | 98.61 Million EUR | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Alcon Inc. | 2.32 Billion USD | 88.556% |
| AptarGroup, Inc. | 513.05 Million USD | 48.222% |
| Baxter International Inc. | 2.82 Billion USD | 90.593% |
| Becton, Dickinson and Company | 3.27 Billion USD | 91.884% |
| Bausch + Lomb Corporation | 1.02 Billion USD | 74.159% |
| Haemonetics Corporation | 317.2 Million USD | 16.253% |
| Envista Holdings Corp | 258.8 Million USD | -2.646% |
| ResMed Inc. | 822.25 Million USD | 67.693% |
| Teleflex Incorporated | 626.21 Million USD | 57.579% |
| Warby Parker Inc. | 62.23 Million USD | -326.852% |
| West Pharmaceutical Services, Inc. | 434.7 Million USD | 38.89% |